P140016/S018: Zenith Alpha/ Alpha 2 Thoracic Endovascular Graft (ZTA/ZTA2)
FDA’s recorded scope: changes to the supplier of packaging materials
Explore this company’s associated devices, FDA decisions and regulatory history.

MedtechLedger currently links 4 FDA records to the applicant name Cook Medical Incorporated. 1 entry is a PMA supplement. 3 entries are 30-day notices. These are records held by this publication, rather than a count of the company’s entire portfolio.
The dated entries run from Sep 18, 2025 to Aug 4, 2026. Individual filings may concern different products or changes to an existing application; review the identifier and decision scope on each record.
Product code MIH appears in 4 of the 4 linked filings. The collection spans 1 FDA product code and 1 original PMA application family. These figures describe the filings available here; they do not establish the company’s total device sales or market share.
The largest PMA family in this collection is P140016, with 4 linked entries. Follow the parent application and its dated supplements to distinguish the original device scope from later changes.
Applicant mailing address recorded by FDA: Sandet 6, Bjaeverskov, 4632. Recorded on P140016/S018, decision dated Aug 4, 2026.
System, Endovascular Graft, Aortic Aneurysm Treatment.
FDA’s recorded scope: changes to the supplier of packaging materials
FDA’s recorded scope: approval for a new supplier for a component of delivery systems of the Zenith (Flex) AAA Endovascular Graft, Zenith Renu AAA Ancillary Graft, Zenith Fenestrated AAA Endovascular Graft, Zenith Alpha & Alpha2 Thoracic Endovascular Graft, Zenith Dissection Endovascular System
FDA’s recorded scope: modifications to nitinol processing steps for components of the delivery systems for the Zenith Alpha 2 Thoracic Endovascular Graft and the Zenith Dissection Endovascular System
FDA’s recorded scope: Approval for a change in coating for the delivery system of the Zenith Alpha 2 Thoracic Endovascular Graft
Subsidiaries and similarly named applicants can have separate records. The links below preserve the applicant and submission identifiers. Source records are linked on each filing.
MedtechLedger links 1 FDA enforcement entry through the recorded recalling firm or an exact submission number published in FDA’s recall data. 1 Class I records are represented. Each row is an enforcement entry; one recall event can cover several product entries. These counts describe this collection and do not measure a manufacturer’s safety record or an injury rate.
| Recall / product | Company | Classification | Report date | Source |
|---|---|---|---|---|
| Cook Medical Incorporated | Class I | Oct 22, 2025 | FDA |
Connections use the recorded recalling firm or the submission identifiers shown below. A shared submission connects the records; it does not establish that differently named legal applicants are interchangeable. Use the exact affected models, lots and instructions on each notice.
Source updated Nov 11, 2026. Retrieved Nov 21, 2026.
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Cook Medical Incorporated | PMA supplement | Aug 4, 2026 | FDA | |
| Cook Medical Incorporated | PMA supplement | May 21, 2026 | FDA | |
Zenith Alpha Thoracic Endovascular GraftP140016/S016 | Cook Medical Incorporated | PMA supplement | May 8, 2026 | FDA |
ZENITH ALPHA THORACIC ENDOVASCULAR GRAFTP140016/S015 | Cook Medical Incorporated | PMA supplement | Sep 18, 2025 | FDA |
Source updated Nov 9, 2026. Retrieved Nov 21, 2026.